LfcinB 17-28 TFA

LfcinB 17-28 TFA, also known as the bovine lactoferricin B peptide fragment 17-28 in trifluoroacetate salt form, is a synthetic antimicrobial peptide derived from the larger lactoferricin protein sequence. This peptide exhibits a unique cationic and amphipathic structure, which enables it to interact efficiently with microbial membranes. Its sequence is specifically designed to harness the bioactive core of lactoferricin B, thereby optimizing its functionality for various research and experimental applications. The TFA salt form ensures enhanced solubility and stability, making it suitable for a wide range of laboratory techniques. Researchers value LfcinB 17-28 TFA for its versatility in microbiological, biochemical, and cellular studies, as well as its potential in exploring host-pathogen interactions. Its robust activity profile and ease of handling make it an indispensable tool in peptide-based research.

Antimicrobial Research: LfcinB 17-28 TFA is widely utilized in antimicrobial research to investigate the mechanisms underlying peptide-membrane interactions and microbial cell disruption. Its ability to permeabilize bacterial membranes is of particular interest, as it allows scientists to study the peptide's selectivity and potency against various Gram-positive and Gram-negative bacterial strains. The peptide's action is generally attributed to its positive charge and hydrophobic regions, which facilitate insertion into lipid bilayers and subsequent cell lysis. By employing this peptide in susceptibility assays or membrane integrity studies, researchers can dissect the structural requirements for antimicrobial activity and potentially identify new therapeutic targets or peptide analogs with improved efficacy.

Biofilm Inhibition Studies: In the context of biofilm research, the bovine lactoferricin B fragment is a valuable agent for probing the inhibition and disruption of microbial biofilms. Biofilms present a significant challenge in both environmental and biomedical settings due to their resistance to conventional antimicrobial agents. LfcinB 17-28 TFA has demonstrated the capacity to interfere with biofilm formation and maintenance, likely through its interaction with extracellular polymeric substances and disruption of microbial communication pathways. Researchers utilize the peptide in in vitro biofilm models to evaluate its efficacy in preventing initial adhesion or in eradicating established biofilms, thereby gaining insights into strategies for controlling persistent microbial communities.

Cellular Uptake and Delivery: The amphipathic nature of LfcinB 17-28 TFA allows it to serve as a model system for studying peptide-mediated cellular uptake and intracellular delivery. Scientists exploit its membrane-penetrating properties to explore how cationic peptides traverse cell membranes, a process relevant for the design of novel delivery vectors for small molecules, nucleic acids, or other therapeutic agents. By conjugating fluorescent tags or cargo molecules to the peptide, researchers can track its internalization pathways and assess its potential as a delivery scaffold in cellular systems, contributing to the broader understanding of peptide-based drug delivery technologies.

Immunomodulatory Research: Beyond its direct antimicrobial effects, LfcinB 17-28 TFA is also investigated for its immunomodulatory properties. Studies have shown that lactoferricin-derived peptides can modulate immune cell responses, such as cytokine production or chemotactic activity. Researchers use the peptide in vitro to examine its influence on immune cell signaling, activation, and migration, thereby elucidating its role in host defense mechanisms. Such studies enhance our comprehension of how innate immunity can be modulated by exogenous peptides and inform the development of immune-supportive compounds for research purposes.

Peptide Engineering and Structure-Activity Relationship Studies: The defined sequence and structural features of LfcinB 17-28 TFA make it an ideal template for peptide engineering and structure-activity relationship (SAR) studies. Scientists frequently employ the peptide as a benchmark to design and synthesize analogs with modified amino acid residues, altered charge distribution, or enhanced stability. By systematically varying these parameters, researchers can delineate the contribution of specific residues to antimicrobial activity, membrane interaction, or other bioactive properties. These investigations not only deepen the understanding of peptide function but also guide the rational design of next-generation bioactive peptides for research and development.

In summary, LfcinB 17-28 TFA stands as a multifaceted research tool with broad applications spanning antimicrobial research, biofilm inhibition, cellular uptake studies, immunomodulatory research, and peptide engineering. Its well-characterized structure and dynamic biological properties enable scientists to explore fundamental questions in microbiology, immunology, and peptide science, driving innovation in experimental methodologies and the discovery of novel bioactive molecules.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling